New drug trial aims to help control diabetes and weight

NCT ID NCT06845202

Recruiting now Disease control Sponsor: Alnylam Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called ALN-4324. It first checks the drug's safety in healthy overweight volunteers. Then, it tests if multiple doses can help control blood sugar in people with type 2 diabetes who are also overweight or obese.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Trial Site
RECRUITING

Miami, Florida, 33126, United States
Clinical Trial Site
RECRUITING

Mount Royal, H3P 3P1, Canada

Conditions

Explore the condition pages connected to this study.

OBESE OR OVERWEIGHT HEALTHY VOLUNTEERS TYPE 2 DIABETES MELLITUS (T2DM)